Revvity, Inc. (NYSE: RVTY) Stock Competitors & Peer Comparison
See RVTY's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for RVTY and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RVTY | $112.52 | -0.90% | 12.6B | 21.98 | $5.12 | +0.25% |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.73% |
| TMO | $574.30 | -0.43% | 213.4B | 24.79 | $23.16 | +0.31% |
| DHR | $194.98 | -0.61% | 137.1B | 24.45 | $7.98 | +0.73% |
| IDXX | $559.07 | +0.05% | 44.1B | 41.17 | $13.58 | N/A |
| A | $138.37 | -0.25% | 39.1B | 23.82 | $5.81 | +0.73% |
| IQV | $235.02 | -1.16% | 38.7B | 19.38 | $12.13 | N/A |
| NTRA | $267.76 | -0.70% | 38.3B | -168.40 | -$1.59 | N/A |
| ILMN | $205.10 | +0.00% | 31B | 40.78 | $5.03 | N/A |
| MTD | $1,416.30 | +2.59% | 28.6B | 32.58 | $43.51 | N/A |
Stock Comparison
Danaher Corporation (NYSE: DHR-PB)
RVTY vs DHR-PB Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, RVTY's ROE is +0.03%, compared to DHR-PB's ROE of +0.08%. Regarding short-term risk, RVTY is more volatile compared to DHR-PB. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check DHR-PB's competition here
Thermo Fisher Scientific Inc. (NYSE: TMO)
RVTY vs TMO Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, TMO has a market cap of 213.4B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while TMO trades at $574.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas TMO's P/E ratio is 24.79. In terms of profitability, RVTY's ROE is +0.03%, compared to TMO's ROE of +0.13%. Regarding short-term risk, RVTY is more volatile compared to TMO. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check TMO's competition here
Danaher Corporation (NYSE: DHR)
RVTY vs DHR Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, DHR has a market cap of 137.1B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while DHR trades at $194.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas DHR's P/E ratio is 24.45. In terms of profitability, RVTY's ROE is +0.03%, compared to DHR's ROE of +0.08%. Regarding short-term risk, RVTY is less volatile compared to DHR. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check DHR's competition here
IDEXX Laboratories, Inc. (NASDAQ: IDXX)
RVTY vs IDXX Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, IDXX has a market cap of 44.1B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while IDXX trades at $559.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas IDXX's P/E ratio is 41.17. In terms of profitability, RVTY's ROE is +0.03%, compared to IDXX's ROE of +0.71%. Regarding short-term risk, RVTY is more volatile compared to IDXX. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check IDXX's competition here
Agilent Technologies, Inc. (NYSE: A)
RVTY vs A Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, A has a market cap of 39.1B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while A trades at $138.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas A's P/E ratio is 23.82. In terms of profitability, RVTY's ROE is +0.03%, compared to A's ROE of +0.21%. Regarding short-term risk, RVTY is more volatile compared to A. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check A's competition here
IQVIA Holdings Inc. (NYSE: IQV)
RVTY vs IQV Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, IQV has a market cap of 38.7B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while IQV trades at $235.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas IQV's P/E ratio is 19.38. In terms of profitability, RVTY's ROE is +0.03%, compared to IQV's ROE of +0.22%. Regarding short-term risk, RVTY is less volatile compared to IQV. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check IQV's competition here
Natera, Inc. (NASDAQ: NTRA)
RVTY vs NTRA Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, NTRA has a market cap of 38.3B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while NTRA trades at $267.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas NTRA's P/E ratio is -168.40. In terms of profitability, RVTY's ROE is +0.03%, compared to NTRA's ROE of -0.15%. Regarding short-term risk, RVTY is less volatile compared to NTRA. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check NTRA's competition here
Illumina, Inc. (NASDAQ: ILMN)
RVTY vs ILMN Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, ILMN has a market cap of 31B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while ILMN trades at $205.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas ILMN's P/E ratio is 40.78. In terms of profitability, RVTY's ROE is +0.03%, compared to ILMN's ROE of +0.31%. Regarding short-term risk, RVTY is less volatile compared to ILMN. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check ILMN's competition here
Mettler-Toledo International Inc. (NYSE: MTD)
RVTY vs MTD Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, MTD has a market cap of 28.6B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while MTD trades at $1,416.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas MTD's P/E ratio is 32.58. In terms of profitability, RVTY's ROE is +0.03%, compared to MTD's ROE of -12.00%. Regarding short-term risk, RVTY is less volatile compared to MTD. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check MTD's competition here
Quest Diagnostics Incorporated (NYSE: DGX)
RVTY vs DGX Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, DGX has a market cap of 25.7B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while DGX trades at $233.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas DGX's P/E ratio is 22.98. In terms of profitability, RVTY's ROE is +0.03%, compared to DGX's ROE of +0.14%. Regarding short-term risk, RVTY is more volatile compared to DGX. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check DGX's competition here
Labcorp Holdings Inc. (NYSE: LH)
RVTY vs LH Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, LH has a market cap of 25.4B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while LH trades at $309.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas LH's P/E ratio is 18.36. In terms of profitability, RVTY's ROE is +0.03%, compared to LH's ROE of +0.12%. Regarding short-term risk, RVTY is less volatile compared to LH. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check LH's competition here
Waters Corporation (NYSE: WAT)
RVTY vs WAT Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, WAT has a market cap of 24.6B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while WAT trades at $377.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas WAT's P/E ratio is 27.78. In terms of profitability, RVTY's ROE is +0.03%, compared to WAT's ROE of +0.08%. Regarding short-term risk, RVTY is less volatile compared to WAT. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check WAT's competition here
Guardant Health, Inc. (NASDAQ: GH)
RVTY vs GH Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, GH has a market cap of 21.5B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while GH trades at $161.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas GH's P/E ratio is -62.79. In terms of profitability, RVTY's ROE is +0.03%, compared to GH's ROE of +2.11%. Regarding short-term risk, RVTY is less volatile compared to GH. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check GH's competition here
Exact Sciences Corporation (NASDAQ: EXAS)
RVTY vs EXAS Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, EXAS has a market cap of 20B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while EXAS trades at $104.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas EXAS's P/E ratio is -95.37. In terms of profitability, RVTY's ROE is +0.03%, compared to EXAS's ROE of -0.09%. Regarding short-term risk, RVTY is more volatile compared to EXAS. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check EXAS's competition here
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV)
RVTY vs ILMNV Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, ILMNV has a market cap of 17B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while ILMNV trades at $107.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas ILMNV's P/E ratio is N/A. In terms of profitability, RVTY's ROE is +0.03%, compared to ILMNV's ROE of N/A. Regarding short-term risk, RVTY is more volatile compared to ILMNV. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check ILMNV's competition here
Medpace Holdings, Inc. (NASDAQ: MEDP)
RVTY vs MEDP Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, MEDP has a market cap of 16.1B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while MEDP trades at $577.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas MEDP's P/E ratio is 36.27. In terms of profitability, RVTY's ROE is +0.03%, compared to MEDP's ROE of +1.10%. Regarding short-term risk, RVTY is more volatile compared to MEDP. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check MEDP's competition here
PerkinElmer, Inc. (NYSE: PKI)
RVTY vs PKI Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas PKI's P/E ratio is 41.45. In terms of profitability, RVTY's ROE is +0.03%, compared to PKI's ROE of +0.03%. Regarding short-term risk, RVTY is more volatile compared to PKI. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check PKI's competition here
ICON Public Limited Company (NASDAQ: ICLR)
RVTY vs ICLR Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, ICLR has a market cap of 12.5B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while ICLR trades at $163.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas ICLR's P/E ratio is 13.34. In terms of profitability, RVTY's ROE is +0.03%, compared to ICLR's ROE of +0.04%. Regarding short-term risk, RVTY is less volatile compared to ICLR. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check ICLR's competition here
Charles River Laboratories International, Inc. (NYSE: CRL)
RVTY vs CRL Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, CRL has a market cap of 11.2B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while CRL trades at $232.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas CRL's P/E ratio is 23.25. In terms of profitability, RVTY's ROE is +0.03%, compared to CRL's ROE of -0.06%. Regarding short-term risk, RVTY is less volatile compared to CRL. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check CRL's competition here
Qiagen N.V. (NYSE: QGEN)
RVTY vs QGEN Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, QGEN has a market cap of 8.5B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while QGEN trades at $41.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas QGEN's P/E ratio is 17.25. In terms of profitability, RVTY's ROE is +0.03%, compared to QGEN's ROE of +0.11%. Regarding short-term risk, RVTY is more volatile compared to QGEN. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check QGEN's competition here
BillionToOne, Inc. (NASDAQ: BLLN)
RVTY vs BLLN Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, BLLN has a market cap of 6.4B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while BLLN trades at $138.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas BLLN's P/E ratio is 252.00. In terms of profitability, RVTY's ROE is +0.03%, compared to BLLN's ROE of +0.08%. Regarding short-term risk, RVTY is less volatile compared to BLLN. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check BLLN's competition here
Twist Bioscience Corporation (NASDAQ: TWST)
RVTY vs TWST Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, TWST has a market cap of 5.7B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while TWST trades at $91.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas TWST's P/E ratio is -42.98. In terms of profitability, RVTY's ROE is +0.03%, compared to TWST's ROE of -0.17%. Regarding short-term risk, RVTY is less volatile compared to TWST. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check TWST's competition here
Sotera Health Company (NASDAQ: SHC)
RVTY vs SHC Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, SHC has a market cap of 5.1B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while SHC trades at $17.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas SHC's P/E ratio is 19.84. In terms of profitability, RVTY's ROE is +0.03%, compared to SHC's ROE of +0.21%. Regarding short-term risk, RVTY is more volatile compared to SHC. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check SHC's competition here
RadNet, Inc. (NASDAQ: RDNT)
RVTY vs RDNT Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, RDNT has a market cap of 5B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while RDNT trades at $63.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas RDNT's P/E ratio is 138.65. In terms of profitability, RVTY's ROE is +0.03%, compared to RDNT's ROE of -0.01%. Regarding short-term risk, RVTY is less volatile compared to RDNT. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check RDNT's competition here
Syneos Health, Inc. (NASDAQ: SYNH)
RVTY vs SYNH Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas SYNH's P/E ratio is 61.40. In terms of profitability, RVTY's ROE is +0.03%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, RVTY is more volatile compared to SYNH. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check SYNH's competition here
Veracyte, Inc. (NASDAQ: VCYT)
RVTY vs VCYT Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, VCYT has a market cap of 3.7B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while VCYT trades at $46.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas VCYT's P/E ratio is 23.16. In terms of profitability, RVTY's ROE is +0.03%, compared to VCYT's ROE of +0.09%. Regarding short-term risk, RVTY is less volatile compared to VCYT. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check VCYT's competition here
Olink Holding AB (publ) (NASDAQ: OLK)
RVTY vs OLK Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas OLK's P/E ratio is -96.59. In terms of profitability, RVTY's ROE is +0.03%, compared to OLK's ROE of -0.07%. Regarding short-term risk, RVTY is more volatile compared to OLK. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check OLK's competition here
Neogen Corporation (NASDAQ: NEOG)
RVTY vs NEOG Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, NEOG has a market cap of 2.6B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while NEOG trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas NEOG's P/E ratio is 43.00. In terms of profitability, RVTY's ROE is +0.03%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, RVTY is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check NEOG's competition here
CareDx, Inc (NASDAQ: CDNA)
RVTY vs CDNA Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, CDNA has a market cap of 2.3B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while CDNA trades at $43.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas CDNA's P/E ratio is 52.04. In terms of profitability, RVTY's ROE is +0.03%, compared to CDNA's ROE of +0.33%. Regarding short-term risk, RVTY is less volatile compared to CDNA. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check CDNA's competition here
Personalis, Inc. (NASDAQ: PSNL)
RVTY vs PSNL Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, PSNL has a market cap of 1.4B. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while PSNL trades at $12.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas PSNL's P/E ratio is -12.41. In terms of profitability, RVTY's ROE is +0.03%, compared to PSNL's ROE of -0.44%. Regarding short-term risk, RVTY is less volatile compared to PSNL. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check PSNL's competition here
Castle Biosciences, Inc. (NASDAQ: CSTL)
RVTY vs CSTL Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, CSTL has a market cap of 849.2M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while CSTL trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas CSTL's P/E ratio is -63.64. In terms of profitability, RVTY's ROE is +0.03%, compared to CSTL's ROE of -0.04%. Regarding short-term risk, RVTY is less volatile compared to CSTL. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check CSTL's competition here
GRAIL, Inc. Common Stock (NASDAQ: GRALV)
RVTY vs GRALV Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas GRALV's P/E ratio is N/A. In terms of profitability, RVTY's ROE is +0.03%, compared to GRALV's ROE of N/A. Regarding short-term risk, RVTY is less volatile compared to GRALV. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check GRALV's competition here
Fulgent Genetics, Inc. (NASDAQ: FLGT)
RVTY vs FLGT Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, FLGT has a market cap of 470M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while FLGT trades at $16.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas FLGT's P/E ratio is 1655.00. In terms of profitability, RVTY's ROE is +0.03%, compared to FLGT's ROE of -0.08%. Regarding short-term risk, RVTY is less volatile compared to FLGT. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check FLGT's competition here
Global Cord Blood Corporation (NYSE: CO)
RVTY vs CO Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas CO's P/E ratio is 5.06. In terms of profitability, RVTY's ROE is +0.03%, compared to CO's ROE of +0.11%. Regarding short-term risk, RVTY is less volatile compared to CO. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check CO's competition here
NeoGenomics, Inc. (NASDAQ: NEO)
RVTY vs NEO Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, NEO has a market cap of 392.9M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while NEO trades at $15.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas NEO's P/E ratio is 117.62. In terms of profitability, RVTY's ROE is +0.03%, compared to NEO's ROE of -0.06%. Regarding short-term risk, RVTY is less volatile compared to NEO. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check NEO's competition here
Prenetics Global Limited (NASDAQ: PRENW)
RVTY vs PRENW Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, PRENW has a market cap of 360.8M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while PRENW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas PRENW's P/E ratio is N/A. In terms of profitability, RVTY's ROE is +0.03%, compared to PRENW's ROE of -0.47%. Regarding short-term risk, RVTY is more volatile compared to PRENW. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check PRENW's competition here
Prenetics Global Limited (NASDAQ: PRE)
RVTY vs PRE Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, PRE has a market cap of 316.9M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while PRE trades at $18.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas PRE's P/E ratio is -9.05. In terms of profitability, RVTY's ROE is +0.03%, compared to PRE's ROE of -0.47%. Regarding short-term risk, RVTY is less volatile compared to PRE. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check PRE's competition here
Standard BioTools Inc. (NASDAQ: FLDM)
RVTY vs FLDM Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, FLDM has a market cap of 294.2M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while FLDM trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas FLDM's P/E ratio is -4.74. In terms of profitability, RVTY's ROE is +0.03%, compared to FLDM's ROE of +0.17%. Regarding short-term risk, RVTY is less volatile compared to FLDM. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check FLDM's competition here
Myriad Genetics, Inc. (NASDAQ: MYGN)
RVTY vs MYGN Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, MYGN has a market cap of 270.1M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while MYGN trades at $2.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas MYGN's P/E ratio is -22.00. In terms of profitability, RVTY's ROE is +0.03%, compared to MYGN's ROE of -0.33%. Regarding short-term risk, RVTY is less volatile compared to MYGN. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check MYGN's competition here
Trinity Biotech plc (NASDAQ: TRIB)
RVTY vs TRIB Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, TRIB has a market cap of 234.9M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while TRIB trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas TRIB's P/E ratio is -3.01. In terms of profitability, RVTY's ROE is +0.03%, compared to TRIB's ROE of +0.68%. Regarding short-term risk, RVTY is less volatile compared to TRIB. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check TRIB's competition here
Biodesix, Inc. (NASDAQ: BDSX)
RVTY vs BDSX Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, BDSX has a market cap of 172.6M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while BDSX trades at $21.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas BDSX's P/E ratio is -5.22. In terms of profitability, RVTY's ROE is +0.03%, compared to BDSX's ROE of -21.01%. Regarding short-term risk, RVTY is less volatile compared to BDSX. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check BDSX's competition here
Insight Molecular Diagnostics Inc. (NASDAQ: IMDX)
RVTY vs IMDX Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, IMDX has a market cap of 150.1M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while IMDX trades at $4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas IMDX's P/E ratio is -3.91. In terms of profitability, RVTY's ROE is +0.03%, compared to IMDX's ROE of +3.81%. Regarding short-term risk, RVTY is less volatile compared to IMDX. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check IMDX's competition here
Genetron Holdings Limited (NASDAQ: GTH)
RVTY vs GTH Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas GTH's P/E ratio is -1.11. In terms of profitability, RVTY's ROE is +0.03%, compared to GTH's ROE of -1.01%. Regarding short-term risk, RVTY is more volatile compared to GTH. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check GTH's competition here
Genetic Technologies Limited (NASDAQ: GENE)
RVTY vs GENE Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas GENE's P/E ratio is -38.25. In terms of profitability, RVTY's ROE is +0.03%, compared to GENE's ROE of -1.85%. Regarding short-term risk, RVTY is more volatile compared to GENE. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check GENE's competition here
Exagen Inc. (NASDAQ: XGN)
RVTY vs XGN Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, XGN has a market cap of 109.4M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while XGN trades at $4.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas XGN's P/E ratio is -6.12. In terms of profitability, RVTY's ROE is +0.03%, compared to XGN's ROE of -1.14%. Regarding short-term risk, RVTY is less volatile compared to XGN. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check XGN's competition here
Sera Prognostics, Inc. (NASDAQ: SERA)
RVTY vs SERA Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, SERA has a market cap of 79.8M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while SERA trades at $2.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas SERA's P/E ratio is -3.22. In terms of profitability, RVTY's ROE is +0.03%, compared to SERA's ROE of -0.41%. Regarding short-term risk, RVTY is less volatile compared to SERA. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check SERA's competition here
Atlantic International Corp. (NASDAQ: ATLN)
RVTY vs ATLN Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, ATLN has a market cap of 73.2M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas ATLN's P/E ratio is -0.68. In terms of profitability, RVTY's ROE is +0.03%, compared to ATLN's ROE of +14.94%. Regarding short-term risk, RVTY is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check ATLN's competition here
DarioHealth Corp. (NASDAQ: DRIO)
RVTY vs DRIO Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, DRIO has a market cap of 53.2M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while DRIO trades at $7.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas DRIO's P/E ratio is -1.24. In terms of profitability, RVTY's ROE is +0.03%, compared to DRIO's ROE of +0.93%. Regarding short-term risk, RVTY is less volatile compared to DRIO. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check DRIO's competition here
Precipio, Inc. (NASDAQ: PRPO)
RVTY vs PRPO Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, PRPO has a market cap of 38.7M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while PRPO trades at $21.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas PRPO's P/E ratio is -83.27. In terms of profitability, RVTY's ROE is +0.03%, compared to PRPO's ROE of -0.07%. Regarding short-term risk, RVTY is less volatile compared to PRPO. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check PRPO's competition here
Akumin Inc. (NASDAQ: AKU)
RVTY vs AKU Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas AKU's P/E ratio is -0.13. In terms of profitability, RVTY's ROE is +0.03%, compared to AKU's ROE of -5.32%. Regarding short-term risk, RVTY is less volatile compared to AKU. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check AKU's competition here
MDxHealth S.A. (NASDAQ: MDXH)
RVTY vs MDXH Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, MDXH has a market cap of 21.5M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while MDXH trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas MDXH's P/E ratio is -1.10. In terms of profitability, RVTY's ROE is +0.03%, compared to MDXH's ROE of +4.03%. Regarding short-term risk, RVTY is less volatile compared to MDXH. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check MDXH's competition here
Chembio Diagnostics, Inc. (NASDAQ: CEMI)
RVTY vs CEMI Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas CEMI's P/E ratio is -0.63. In terms of profitability, RVTY's ROE is +0.03%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, RVTY is more volatile compared to CEMI. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check CEMI's competition here
Enzo Biochem, Inc. (NYSE: ENZ)
RVTY vs ENZ Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas ENZ's P/E ratio is -2.24. In terms of profitability, RVTY's ROE is +0.03%, compared to ENZ's ROE of -0.10%. Regarding short-term risk, RVTY is less volatile compared to ENZ. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check ENZ's competition here
Psychemedics Corporation (NASDAQ: PMD)
RVTY vs PMD Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, PMD has a market cap of 15.6M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas PMD's P/E ratio is -5.24. In terms of profitability, RVTY's ROE is +0.03%, compared to PMD's ROE of -0.32%. Regarding short-term risk, RVTY is more volatile compared to PMD. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check PMD's competition here
23andMe Holding Co. (NASDAQ: ME)
RVTY vs ME Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, ME has a market cap of 15.3M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas ME's P/E ratio is -0.03. In terms of profitability, RVTY's ROE is +0.03%, compared to ME's ROE of -42.03%. Regarding short-term risk, RVTY is more volatile compared to ME. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check ME's competition here
Mainz Biomed B.V. (NASDAQ: MYNZ)
RVTY vs MYNZ Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, MYNZ has a market cap of 14.7M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while MYNZ trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas MYNZ's P/E ratio is -0.68. In terms of profitability, RVTY's ROE is +0.03%, compared to MYNZ's ROE of -10.25%. Regarding short-term risk, RVTY is less volatile compared to MYNZ. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check MYNZ's competition here
Quantum Cyber N.V. (NASDAQ: QUCY)
RVTY vs QUCY Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, QUCY has a market cap of 14.3M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while QUCY trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas QUCY's P/E ratio is -0.05. In terms of profitability, RVTY's ROE is +0.03%, compared to QUCY's ROE of -3.26%. Regarding short-term risk, RVTY is less volatile compared to QUCY. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check QUCY's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
RVTY vs BNGO Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, BNGO has a market cap of 12.3M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while BNGO trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas BNGO's P/E ratio is -0.24. In terms of profitability, RVTY's ROE is +0.03%, compared to BNGO's ROE of -0.71%. Regarding short-term risk, RVTY is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check BNGO's competition here
Check-Cap Ltd. (NASDAQ: CHEK)
RVTY vs CHEK Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, CHEK has a market cap of 10.9M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while CHEK trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas CHEK's P/E ratio is -0.43. In terms of profitability, RVTY's ROE is +0.03%, compared to CHEK's ROE of -2.26%. Regarding short-term risk, RVTY is less volatile compared to CHEK. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check CHEK's competition here
Centogene N.V. (NASDAQ: CNTG)
RVTY vs CNTG Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas CNTG's P/E ratio is -0.23. In terms of profitability, RVTY's ROE is +0.03%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, RVTY is more volatile compared to CNTG. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check CNTG's competition here
Burning Rock Biotech Limited (NASDAQ: BNR)
RVTY vs BNR Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, BNR has a market cap of 9.3M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while BNR trades at $8.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas BNR's P/E ratio is -10.73. In terms of profitability, RVTY's ROE is +0.03%, compared to BNR's ROE of -0.11%. Regarding short-term risk, RVTY is more volatile compared to BNR. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check BNR's competition here
Advanced Biomed Inc. Common Stock (NASDAQ: ADVB)
RVTY vs ADVB Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, ADVB has a market cap of 8.7M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while ADVB trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas ADVB's P/E ratio is -72.73. In terms of profitability, RVTY's ROE is +0.03%, compared to ADVB's ROE of -0.21%. Regarding short-term risk, RVTY is less volatile compared to ADVB. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check ADVB's competition here
Check-Cap Ltd. Ordinary Share (NASDAQ: MBAI)
RVTY vs MBAI Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, MBAI has a market cap of 7.4M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while MBAI trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas MBAI's P/E ratio is 1.58. In terms of profitability, RVTY's ROE is +0.03%, compared to MBAI's ROE of +4.17%. Regarding short-term risk, RVTY is less volatile compared to MBAI. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check MBAI's competition here
Applied DNA Sciences, Inc. (NASDAQ: APDN)
RVTY vs APDN Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, APDN has a market cap of 7.3M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while APDN trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas APDN's P/E ratio is -0.10. In terms of profitability, RVTY's ROE is +0.03%, compared to APDN's ROE of -6.53%. Regarding short-term risk, RVTY is less volatile compared to APDN. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check APDN's competition here
Invitae Corporation (NYSE: NVTA)
RVTY vs NVTA Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas NVTA's P/E ratio is -0.00. In terms of profitability, RVTY's ROE is +0.03%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, RVTY is less volatile compared to NVTA. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check NVTA's competition here
LumiraDx Limited (NASDAQ: LMDX)
RVTY vs LMDX Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas LMDX's P/E ratio is -0.01. In terms of profitability, RVTY's ROE is +0.03%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, RVTY is less volatile compared to LMDX. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check LMDX's competition here
LumiraDx Limited (NASDAQ: LMDXW)
RVTY vs LMDXW Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, RVTY's ROE is +0.03%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, RVTY is less volatile compared to LMDXW. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check LMDXW's competition here
ENDRA Life Sciences Inc. (NASDAQ: NDRA)
RVTY vs NDRA Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, NDRA has a market cap of 3.6M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while NDRA trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas NDRA's P/E ratio is -0.61. In terms of profitability, RVTY's ROE is +0.03%, compared to NDRA's ROE of -5.13%. Regarding short-term risk, RVTY is less volatile compared to NDRA. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check NDRA's competition here
DermTech, Inc. (NASDAQ: DMTK)
RVTY vs DMTK Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas DMTK's P/E ratio is -0.04. In terms of profitability, RVTY's ROE is +0.03%, compared to DMTK's ROE of -1.06%. Regarding short-term risk, RVTY is less volatile compared to DMTK. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check DMTK's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAF)
RVTY vs BIAF Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, BIAF has a market cap of 2.8M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while BIAF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas BIAF's P/E ratio is -0.07. In terms of profitability, RVTY's ROE is +0.03%, compared to BIAF's ROE of -3.59%. Regarding short-term risk, RVTY is less volatile compared to BIAF. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check BIAF's competition here
Inotiv, Inc. (NASDAQ: NOTV)
RVTY vs NOTV Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, NOTV has a market cap of 2.8M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while NOTV trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas NOTV's P/E ratio is -0.03. In terms of profitability, RVTY's ROE is +0.03%, compared to NOTV's ROE of -0.75%. Regarding short-term risk, RVTY is less volatile compared to NOTV. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check NOTV's competition here
SeqLL Inc. (NASDAQ: SQL)
RVTY vs SQL Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas SQL's P/E ratio is -0.40. In terms of profitability, RVTY's ROE is +0.03%, compared to SQL's ROE of +38.02%. Regarding short-term risk, RVTY is less volatile compared to SQL. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check SQL's competition here
Aspira Women's Health Inc. (NASDAQ: AWH)
RVTY vs AWH Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, AWH has a market cap of 2.5M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas AWH's P/E ratio is -0.09. In terms of profitability, RVTY's ROE is +0.03%, compared to AWH's ROE of +2.03%. Regarding short-term risk, RVTY is more volatile compared to AWH. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check AWH's competition here
Intelligent Bio Solutions Inc. (NASDAQ: INBS)
RVTY vs INBS Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, INBS has a market cap of 1.2M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while INBS trades at $1.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas INBS's P/E ratio is -0.21. In terms of profitability, RVTY's ROE is +0.03%, compared to INBS's ROE of -1.74%. Regarding short-term risk, RVTY is less volatile compared to INBS. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check INBS's competition here
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM)
RVTY vs HTGM Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas HTGM's P/E ratio is -0.03. In terms of profitability, RVTY's ROE is +0.03%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, RVTY is more volatile compared to HTGM. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check HTGM's competition here
Biocept, Inc. (NASDAQ: BIOC)
RVTY vs BIOC Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas BIOC's P/E ratio is -0.01. In terms of profitability, RVTY's ROE is +0.03%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, RVTY is less volatile compared to BIOC. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check BIOC's competition here
iSpecimen Inc. (NASDAQ: ISPC)
RVTY vs ISPC Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, ISPC has a market cap of 262.4K. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while ISPC trades at $1.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas ISPC's P/E ratio is -0.06. In terms of profitability, RVTY's ROE is +0.03%, compared to ISPC's ROE of -5.85%. Regarding short-term risk, RVTY is less volatile compared to ISPC. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check ISPC's competition here
SeqLL Inc. (NASDAQ: SQLLW)
RVTY vs SQLLW Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, SQLLW has a market cap of 179.6K. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas SQLLW's P/E ratio is -0.00. In terms of profitability, RVTY's ROE is +0.03%, compared to SQLLW's ROE of +38.02%. Regarding short-term risk, RVTY is less volatile compared to SQLLW. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check SQLLW's competition here
Check-Cap Ltd (NASDAQ: CHEKZ)
RVTY vs CHEKZ Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, CHEKZ has a market cap of 0. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while CHEKZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas CHEKZ's P/E ratio is N/A. In terms of profitability, RVTY's ROE is +0.03%, compared to CHEKZ's ROE of +4.17%. Regarding short-term risk, RVTY is less volatile compared to CHEKZ. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check CHEKZ's competition here
23andMe Holding Co. (NASDAQ: MEUSW)
RVTY vs MEUSW Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas MEUSW's P/E ratio is N/A. In terms of profitability, RVTY's ROE is +0.03%, compared to MEUSW's ROE of -42.03%. Regarding short-term risk, RVTY is less volatile compared to MEUSW. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check MEUSW's competition here
PAREXEL Intl Corp. (NASDAQ: PRXL)
RVTY vs PRXL Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, PRXL has a market cap of 0. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while PRXL trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas PRXL's P/E ratio is 42.97. In terms of profitability, RVTY's ROE is +0.03%, compared to PRXL's ROE of +0.17%. Regarding short-term risk, RVTY is more volatile compared to PRXL. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check PRXL's competition here
Danaher Corporation (NYSE: DHR-PA)
RVTY vs DHR-PA Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, RVTY's ROE is +0.03%, compared to DHR-PA's ROE of +0.08%. Regarding short-term risk, RVTY is more volatile compared to DHR-PA. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check DHR-PA's competition here
Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)
RVTY vs OCDX Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, OCDX has a market cap of 0. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas OCDX's P/E ratio is -42.28. In terms of profitability, RVTY's ROE is +0.03%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, RVTY is more volatile compared to OCDX. This indicates higher risk in terms of short-term price fluctuations for RVTY.Check OCDX's competition here
ENDRA Life Sciences Inc. Warrants (NASDAQ: NDRAW)
RVTY vs NDRAW Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, NDRAW has a market cap of 0. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while NDRAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas NDRAW's P/E ratio is N/A. In terms of profitability, RVTY's ROE is +0.03%, compared to NDRAW's ROE of -5.13%. Regarding short-term risk, RVTY is less volatile compared to NDRAW. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check NDRAW's competition here
BioNano Genomics, Inc. WT EXP 082123 (NASDAQ: BNGOW)
RVTY vs BNGOW Comparison August 2026
Revvity, Inc. (NYSE: RVTY) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVTY stands at 12.6B. In comparison, BNGOW has a market cap of 0. Regarding current trading prices, RVTY is priced at $112.52 on the NYSE, while BNGOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVTY currently has a P/E ratio of 21.98, whereas BNGOW's P/E ratio is N/A. In terms of profitability, RVTY's ROE is +0.03%, compared to BNGOW's ROE of -0.71%. Regarding short-term risk, RVTY is less volatile compared to BNGOW. This indicates lower risk in terms of short-term price fluctuations for RVTY.Check BNGOW's competition here